Description: Taj Pharma India is Best Known Manufacturer, Exporter and Supplier Colistimethate Sodium for Injection IP 3MIU from Vapi, Gujarat India. Colistimethate Sodium for Injection IP is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby. Taj Pharma is a trusted name in the pharmaceutical industry, recognized as a top manufacturer and global exporter of Colistimethate Sodium for Injection IP 3MIU from Vapi, Gujarat, India. This potent antibiotic is essential in treating serious bacterial infections, particularly those caused by multidrug-resistant Gram-negative pathogens such as Pseudomonas aeruginosa and Klebsiella pneumoniae. Colistimethate Sodium is primarily used in hospital and ICU settings, administered under strict medical supervision. Taj Pharma’s Colistimethate Sodium for Injection IP 3MIU is produced in a WHO-GMP certified facility, ensuring the highest standards of quality, safety, and efficacy. The injection is widely accepted across India, Africa, the Middle East, and LATAM for its reliability and therapeutic effectiveness. While generally safe, it should be used cautiously in patients with kidney issues and avoided during pregnancy unless prescribed. It is considered likely safe during breastfeeding. Taj Pharma also supports PCD Pharma franchise opportunities across India, offering excellent business support, marketing tools, and timely delivery. Known for competitive pricing and regulatory compliance, Taj Pharma continues to be the preferred choice for hospitals, pharmacies, and global pharmaceutical distributors seeking Colistimethate Sodium Injection IP 3MIU. Taj Pharma India is well recognized Manufacturer, Exporter and Supplier of Colistimethate Sodium for Injection IP 3MIU from Vapi, Gujarat India. Colistimethate Sodium for Injection IP 3MIU include Slurred speech, upset stomach, gastrointestinal disturbance, generalized itching, red spots or bumps, increased blood urea nitrogen, increased creatinine level in blood, decreased creatinine clearance, respiratory distress, apnea (absence of breathing), renal toxicity, decreased urinary volume, dizziness, paresthesia (tingling or pricking sensation), vertigo, rash, and fever.
Dimensions: 2560 x 1707
File Type: jpeg
File Size: 281 KB
